DK112732B - Fremgangsmåde til fremstilling af 9-(γ-methylaminopropyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af 9-(γ-methylaminopropyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.

Info

Publication number
DK112732B
DK112732B DK44567AA DK44567A DK112732B DK 112732 B DK112732 B DK 112732B DK 44567A A DK44567A A DK 44567AA DK 44567 A DK44567 A DK 44567A DK 112732 B DK112732 B DK 112732B
Authority
DK
Denmark
Prior art keywords
methylaminopropyl
ethano
anthracene
dihydro
preparation
Prior art date
Application number
DK44567AA
Other languages
English (en)
Inventor
Sa Ciba
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DK112732B publication Critical patent/DK112732B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/38Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/44Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK44567AA 1961-10-10 1967-01-25 Fremgangsmåde til fremstilling af 9-(γ-methylaminopropyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf. DK112732B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1171061 1961-10-10
CH1343463A CH433333A (de) 1961-10-10 1963-11-01 Verfahren zur Herstellung eines neuen Amins
CH1663764A CH451923A (de) 1961-10-10 1964-12-23 Verfahren zur Herstellung eines neuen Amins
CH1617765 1965-11-24

Publications (1)

Publication Number Publication Date
DK112732B true DK112732B (da) 1969-01-13

Family

ID=27429384

Family Applications (4)

Application Number Title Priority Date Filing Date
DK656365AA DK130174B (da) 1961-10-10 1965-12-22 Analogifremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.
DK44567AA DK112732B (da) 1961-10-10 1967-01-25 Fremgangsmåde til fremstilling af 9-(γ-methylaminopropyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.
DK44667AA DK116731B (da) 1961-10-10 1967-01-25 Fremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9, 10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.
DK44467AA DK116938B (da) 1961-10-10 1967-01-25 Fremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK656365AA DK130174B (da) 1961-10-10 1965-12-22 Analogifremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK44667AA DK116731B (da) 1961-10-10 1967-01-25 Fremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9, 10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.
DK44467AA DK116938B (da) 1961-10-10 1967-01-25 Fremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.

Country Status (13)

Country Link
US (1) US3399201A (da)
BE (2) BE655086A (da)
BR (2) BR6463861D0 (da)
CH (2) CH433333A (da)
CY (1) CY557A (da)
DE (1) DE1518691B1 (da)
DK (4) DK130174B (da)
FR (2) FR1461098A (da)
GB (2) GB1022879A (da)
IT (1) IT1059652B (da)
NL (3) NL141382B (da)
SE (4) SE307790B (da)
YU (6) YU32601B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911017A (en) * 1969-04-04 1975-10-07 Sandoz Ag 5-Aminomethyl-5H-dibenzo{8 a,d{9 cycloheptenes
US3870796A (en) * 1970-11-27 1975-03-11 Ciba Geigy Corp Pharmaceutical preparation
US4017542A (en) * 1971-02-23 1977-04-12 Ciba-Geigy Corporation 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and salts thereof
US3903170A (en) * 1971-02-23 1975-09-02 Ciba Geigy Corp Anthryl substituted acrolein compounds
US4045580A (en) * 1971-02-23 1977-08-30 Ciba-Geigy Corporation Pharmaceutical preparation using 9-(2-hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes as antidepressants
AR204070A1 (es) * 1971-02-23 1975-11-20 Ciba Geigy Ag Procedimiento para la elaboracion de nuevos compuestos derivados de 9-(2-hidroxi-3-amino-propil)-9,10-dihidro-9,10-etano-antraceno
CA1021351A (en) * 1971-02-23 1977-11-22 Ciba-Geigy Ag Preparation of 9-(3-oxo-1-propenyl)-9,10-dihydro-9,10-ethano-anthracenes
US4224344A (en) * 1974-12-13 1980-09-23 Sumitomo Chemical Company, Limited Organic tricyclic compounds
US4358620A (en) * 1974-12-13 1982-11-09 Sumitomo Chemical Company, Limited 9-Formyl-9,10-dihydro-9,10-methanoanthracene
CA1056842A (en) * 1975-06-12 1979-06-19 Masayuki Narisada Dihydroethanoanthracene derivatives
JPS527972A (en) * 1975-07-07 1977-01-21 Sumitomo Chem Co Ltd Process for preparing novel morpholine derivatives
GB1531278A (en) * 1975-12-15 1978-11-08 Shionogi & Co 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
US4318926A (en) * 1979-08-14 1982-03-09 Ciba-Geigy Corporation Method of curing or alleviating herpes infections and pharmaceutical compositions suitable therefor
US5512575A (en) * 1991-08-15 1996-04-30 Zeneca Limited Methanoanthraceneyl methyl piperidinyl compounds
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents
AU2004271800A1 (en) 2003-09-12 2005-03-24 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
EP1691811B1 (en) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2614289A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT230365B (de) * 1960-11-29 1963-12-10 Ciba Geigy Verfahren zur Herstellung neuer 9-Aminoalkyl-9,10-dihydro-9,10-äthano-(1',2')-anthrazene und deren Salze bzw. quaternären Ammoniumverbindungen

Also Published As

Publication number Publication date
IT1059652B (it) 1982-06-21
GB1069069A (en) 1967-05-17
YU190273A (en) 1978-05-15
GB1022879A (en) 1966-03-16
SE327707B (da) 1970-08-31
SE344060B (da) 1972-03-27
DK116731B (da) 1970-02-09
DK130174C (da) 1975-06-16
DE1518691B1 (de) 1970-06-18
US3399201A (en) 1968-08-27
NL141382B (nl) 1974-05-15
YU214265A (en) 1974-10-31
YU34022B (en) 1978-10-31
FR1461098A (fr) 1966-12-10
BE674185A (da)
SE327407B (da) 1970-08-24
YU190573A (en) 1978-05-15
NL6412653A (da) 1965-05-03
YU34025B (en) 1978-10-31
YU190373A (en) 1978-05-15
BE655086A (da) 1965-04-30
YU34021B (en) 1978-10-31
DK130174B (da) 1975-01-06
SE307790B (da) 1969-01-20
YU190473A (en) 1978-05-15
YU32601B (en) 1975-04-30
BR6463861D0 (pt) 1973-08-09
BR6575907D0 (pt) 1973-09-06
CY557A (en) 1970-08-19
NL127069C (da)
YU190173A (en) 1978-05-15
CH451923A (de) 1968-05-15
CH433333A (de) 1967-04-15
FR5533M (da) 1967-11-13
YU34023B (en) 1978-10-31
DE1445638B2 (de) 1973-01-04
DE1445638A1 (de) 1969-05-29
DK116938B (da) 1970-03-02
NL6516749A (da) 1966-06-24
YU34024B (en) 1978-10-31

Similar Documents

Publication Publication Date Title
DK116938B (da) Fremgangsmåde til fremstilling af 9-(γ-methylamino-propyl)-9,10-dihydro-9,10-ethano-(1,2)-anthracen eller syreadditionssalte deraf.
DK109037C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK104460C (da) Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.
DK114559B (da) Fremgangsmåde til fremstilling af hydroxydiaminer eller syreadditionssalte deraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK103672C (da) Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf.
DK109676C (da) Fremgangsmåde til fremstilling af primære alkylphenylalkylaminer eller syreadditionssalte deraf.
DK106141C (da) Fremgangsmåde til fremstilling af benzylguanidiner eller syreadditionssalte heraf.
DK96113C (da) Fremgangsmåde til fremstilling af o-benzylphenoxy-β-1-piperidinopropan eller syreadditionssalte deraf.
DK107356C (da) Fremgangsmåde til fremstilling af i 9-stillingen substituerede thiaxantener eller syreadditionssalte heraf.
DK102083C (da) Fremgangsmåde til fremstilling af 8-substituerede 5-β-dimethylaminoethyl-10,11-dihydro-11-oxo-5-dibenzo-(b,e) (1,4)diazepiner eller syreadditionssalte deraf.
DK107555C (da) Fremgangsmåde til fremstilling af 1,4-benzo-diazepin-4-oxider eller syreadditionssalte deraf.
DK100556C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.
DK107225C (da) Fremgangsmåde til fremstilling af bis-aralkylaminoalkyl-cyclohexaner eller syreadditionssalte heraf.
DK107418C (da) Fremgangsmåde til fremstilling af phenoxyalkylaminoguanidiner eller syreadditionssalte heraf.
DK100557C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.
DK100427C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.
DK97400C (da) Fremgangsmåde til fremstilling af 9,10-dihydroantracenderivater eller syreadditionssalte deraf.
DK101240C (da) Fremgangsmåde til fremstilling af 1,1-dicyclohexyl-2-(2-piperidyl-ethylen eller syreadditionssalte heraf.
DK96892C (da) Fremgangsmåde til fremstilling af diphenylalkanderivater eller syreadditionssalte heraf.
DK99509C (da) Fremgangsmåde til fremstilling af diphenylalkanderivater eller syreadditionssalte deraf.
DK96985C (da) Fremgangsmåde til fremstilling af diphenylalkanderivater eller syreadditionsalte heraf.
DK96743C (da) Fremgangsmåde til fremstilling af diphenylalkanderivater eller syreadditionssalte heraf.
DK96837C (da) Fremgangsmåde til fremstilling af diphenylalkanderivater eller syreadditionssalte heraf.